Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 15.

Danzer, C; Eckhardt, K; Schmidt, A; Fankhauser, N; Ribrioux, S; Wollscheid, B; Müller, L; Schiess, R; Zuellig, R; Lehmann, R; Spinas, G; Aebersold, R; Krek, W (2012). A comprehensive description of the N-glycoproteome of mouse pancreatic β-cells and human islets. Journal of Proteome Research, 11(3):1598-1608.

Vats, D; Wang, H; Esterhazy, D; Dikaiou, K; Danzer, C; Honer, M; Stuker, F; Matile, H; Migliorini, C; Fischer, E; Ripoll, J; Keist, R; Krek, W; Schibli, R; Stoffel, M; Rudin, M (2012). Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia, 55(9):2407-2416.

Cima, I; Schiess, R; Wild, P; Kaelin, M; Schüffler, P; Lange, V; Picotti, P; Ossola, R; Templeton, A; Schubert, O; Fuchs, T; Leippold, T; Wyler, S; Zehetner, J; Jochum, W; Buhmann, J M; Cerny, T; Moch, H; Gillessen, S; Aebersold, R; Krek, W (2011). Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 108(8):3342-3347.

Ye, Q; Danzer, C F; Fuchs, A; Krek, W; Mueggler, T; Baltes, C; Rudin, M (2011). Longitudinal evaluation of intramyocellular lipids (IMCLs) in tibialis anterior muscle of ob/ob and ob/+ control mice using a cryogenic surface coil at 9.4 T. NMR in Biomedicine, 24(10):1295-1301.

Kälin, M; Cima, I; Schiess, R; Fankhauser, N; Powles, T; Wild, P; Templeton, A; Cerny, T; Aebersold, R; Krek, W; Gillessen, S (2011). Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome. European Urology, 60(6):1235-1243.

Theurillat, J P; Metzler, S C; Henzi, N; Djouder, N; Helbling, M; Zimmermann, A K; Jacob, F; Soltermann, A; Caduff, R; Heinzelmann-Schwarz, V; Moch, H; Krek, W (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell, 19(3):317-332.

Djouder, N; Tuerk, R D; Suter, M; Salvioni, P; Thali, R F; Scholz, R; Vaahtomeri, K; Auchli, Y; Rechsteiner, H; Brunisholz, R A; Viollet, B; Mäkelä, T P; Wallimann, T; Neumann, D; Krek, W (2010). PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis. EMBO Journal, 29(2):469-481.

Krishnan, J; Suter, M; Windak, R; Krebs, T; Felley, A; Montessuit, C; Tokarska-Schlattner, M; Aasum, E; Bogdanova, A; Perriard, E; Perriard, J C; Larsen, T; Pedrazzini, T; Krek, W (2009). Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metabolism, 9(6):512-524.

Thoma, C R; Toso, A; Gutbrodt, K L; Reggi, S P; Frew, I J; Schraml, Peter; Hergovich, A; Moch, H; Meraldi, P; Krek, W (2009). VHL loss causes spindle misorientation and chromosome instability. Nature Cell Biology, 11(8):994-1001.

Frew, I J; Minola, A; Georgiev, S; Hitz, M; Moch, H; Richard, S; Vortmeyer, A O; Krek, W (2008). Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia. Molecular and Cellular Biology, 28(14):4536-4548.

Schraml, P; Frew, I J; Thoma, C R; Boysen, G; Struckmann, K; Krek, W; Moch, H (2008). Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia. Modern Pathology, 22(1):31-36.

Frew, I J; Thoma, C R; Georgiev, S; Minola, A; Hitz, M; Montani, M; Moch, H; Krek, W (2008). pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation. EMBO Journal, 27(12):1747-1757.

Struckmann, K; Mertz, K; Steu, S; Storz, M; Staller, P; Krek, W; Schraml, P; Moch, H (2008). pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma. Journal of Pathology, 214(4):464-471.

Zhao, J; Yart, A; Frigerio, S; Perren, A; Schraml, P; Weisstanner, C; Stallmach, T; Krek, W; Moch, H (2007). Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene. Oncogene, 26(23):3440-3449.

Parusel, C T; Kritikou, E A; Hengartner, M O; Krek, W; Gotta, M (2006). URI-1 is required for DNA stability in C. elegans. Development, 113(4):621-629.

This list was generated on Mon Oct 23 01:22:35 2017 CEST.